You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Details for New Drug Application (NDA): 205175

✉ Email this page to a colleague

NDA 205175 describes ECOZA, which is a drug marketed by Resilia Pharms and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the ECOZA profile page.

The generic ingredient in ECOZA is econazole nitrate. There are eleven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the econazole nitrate profile page.

Summary for 205175

Tradename:	ECOZA
Applicant:	Resilia Pharms
Ingredient:	econazole nitrate
Patents:	1

Pharmacology for NDA: 205175

Medical Subject Heading (MeSH) Categories for 205175

14-alpha Demethylase Inhibitors
Antifungal Agents

Suppliers and Packaging for NDA: 205175

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ECOZA	econazole nitrate	AEROSOL, FOAM;TOPICAL	205175	NDA AUTHORIZED GENERIC	Trifluent Pharma, LLC	73352-100	73352-100-70	1 CANISTER in 1 CARTON (73352-100-70) / 70 g in 1 CANISTER
ECOZA	econazole nitrate	AEROSOL, FOAM;TOPICAL	205175	NDA	Resilia Pharmaceuticals, Inc.	81811-100	81811-100-70	1 CANISTER in 1 CARTON (81811-100-70) / 70 g in 1 CANISTER

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	AEROSOL, FOAM;TOPICAL			Strength	1%
Approval Date:	Oct 24, 2013	TE:		RLD:	Yes
Patent:	10,071,054	Patent Expiration:	Aug 8, 2031	Product Flag?	Y	Substance Flag?		Delist Request?

Expired US Patents for NDA 205175

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Resilia Pharms	ECOZA	econazole nitrate	AEROSOL, FOAM;TOPICAL	205175-001	Oct 24, 2013	5,993,830	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.